The Centers for Disease Control and Prevention's maternal health response to 2009 H1N1 influenza

Mosby, Laura G.; Ellington, Sascha; Forhan, Sara E.; Yeung, Lorraine F.; Perez, Mirna; Shah, Melisa M; MacFarlane, Kitty; Laird, Susan; House, L. Duane; Jamieson, Denise J.

doi:10.1016/j.ajog.2011.02.057

Cited by 27 publications

(36 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, it was noted that among patients who acquired this infection, pregnant women were approximately 4-5 times more likely to develop severe disease than nonpregnant women (8). Since then, our knowledge about influenza infection during pregnancy has greatly expanded with regard to both diagnostic and treatment information, and much more attention has been focused on the issue of influenza in pregnancy (9)(10)(11).…”

Section: Introductionmentioning

confidence: 99%

Pandemic Influenza A (H1N1) Infection in Pregnant and Nonpregnant Women in Spain (2009–2010)

Suárez-Varela

Gónzález-Candelas

Astray³

et al. 2014

Jpn J Infect Dis

View full text Add to dashboard Cite

SUMMARY:The present study aimed to compare the main features of infection with pandemic influenza A virus in pregnant and nonpregnant women admitted to hospitals in Spain during the first waves of the 2009-2010 influenza pandemic. This was a prospective (November 2009 to June 2010), multicenter observational study. All cases were women of reproductive age who had not been vaccinated against seasonal or pandemic influenza A. Influenza infection was confirmed by reverse transcriptionpolymerase chain reaction (RT-PCR). The sociodemographic and clinical data of all cases were reviewed. A total of 219 inpatients, including 49 pregnant women and 170 nonpregnant women, were enrolled in the study upon admission to participating hospitals. The most substantially different symptoms between the groups were respiratory distress and unilobar consolidation, both of which were more frequent among nonpregnant women. Antibiotics and systemic corticosteroids were more frequently used in nonpregnant women; however, there were no differences in the rates of treatment with antivirals. Our findings indicated that the compared with nonpregnant women, pregnant women in this study did not have significantly different symptoms and were not at increased risk of complications from pandemic influenza virus infection.

show abstract

Section: Introductionmentioning

confidence: 99%

Pandemic Influenza A (H1N1) Infection in Pregnant and Nonpregnant Women in Spain (2009–2010)

Suárez-Varela

Gónzález-Candelas

Astray³

et al. 2014

Jpn J Infect Dis

View full text Add to dashboard Cite

show abstract

“…This is the second time that the MHT was activated as part of an emergency response; the initial activation was during the 2009–2010 Pandemic H1N1 Influenza response. 6 The Ebola outbreak in West Africa officially ended in December 2015 when Guinea was declared Ebola free. 1 On March 29, 2016, WHO declared that the Ebola outbreak in West Africa no longer constituted a public health emergency.…”

Section: Descriptionmentioning

confidence: 99%

“…6 Analyses of maternal health inquiries received during the response highlighted needs of the U.S. pregnant population and salient questions asked by medical and public health professionals and the general public.…”

Section: Descriptionmentioning

confidence: 99%

Addressing Maternal Health During CDC's Ebola Response in the United States

Ellington

Perez

Morof

et al. 2017

Journal of Women's Health

Self Cite

View full text Add to dashboard Cite

Previous outbreaks suggest that pregnant women with Ebola virus disease (EVD) are at increased risk for severe disease and death. Healthcare workers who treat pregnant women with EVD are at increased risk of body fluid exposure. Despite the absence of pregnant women with EVD in the United States, CDC activated the Maternal Health Team (MHT), a functional unit dedicated to emergency preparedness and response issues, on October 18, 2014. We describe major activities of the MHT. A high-priority MHT activity was to publish guiding principles early in the response. The MHT also prepared guidance documents, provided guidance and technical support for hospital preparedness, and addressed inquiries. We analyzed maternal health inquiries received through CDC-INFO, MHT, and CDC’s Medical Investigations Team from August 2014 to December 2015. Internal call logs used to capture, monitor, and track inquiries for the three data sources were merged. Inquiries not related to maternal health issues and duplicates were removed. Each inquiry was categorized by route (email/phone), inquirer type, and topic. In total, 201 inquiries were received from clinicians, public health professionals, and the public. The predominant topic was related to infection control for high-risk situations such as labor and delivery. During the Ebola response, most inquiries were received via email rather than telephone, a notable shift compared to the H1N1 emergency response. Lessons learned during the H1N1 and Ebola responses are currently informing CDC’s Zika Response, an unprecedented emergency response primarily focused on reproductive health issues.

show abstract

“…16,17 In addition, pregnancy-associated changes in pulmonary and cardiovascular function including decreased lung capacity and tidal volume, increased cardiac output and oxygen consumption, may also contribute to worse influenza infection outcomes, as reported during the 2009 influenza pandemic. 18,19 Hence, the combination of pregnancy-associated changes in physiology plus dysregulated immune responses leave pregnant women particularly vulnerable to serious influenza-related complications, raising the important question of whether these adverse outcomes could be prevented by influenza immunization of all pregnant women.…”

Section: Pregnancy-associated Immunological Changes Affecting Vaccinementioning

confidence: 99%

Influenza immunization during pregnancy: Benefits for mother and infant

Sakala

Honda‐Okubo

Fung

et al. 2016

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

The Centers for Disease Control and Prevention's maternal health response to 2009 H1N1 influenza

Cited by 27 publications

References 9 publications

Pandemic Influenza A (H1N1) Infection in Pregnant and Nonpregnant Women in Spain (2009–2010)

Pandemic Influenza A (H1N1) Infection in Pregnant and Nonpregnant Women in Spain (2009–2010)

Addressing Maternal Health During CDC's Ebola Response in the United States

Influenza immunization during pregnancy: Benefits for mother and infant

Contact Info

Product

Resources

About

The Centers for Disease Control and Prevention's maternal health response to 2009 H1N1 influenza

Cited by 27 publications

References 9 publications

Pandemic Influenza A (H1N1) Infection in Pregnant and Nonpregnant Women in Spain (2009&ndash;2010)

Pandemic Influenza A (H1N1) Infection in Pregnant and Nonpregnant Women in Spain (2009&ndash;2010)

Addressing Maternal Health During CDC's Ebola Response in the United States

Influenza immunization during pregnancy: Benefits for mother and infant

Contact Info

Product

Resources

About

Pandemic Influenza A (H1N1) Infection in Pregnant and Nonpregnant Women in Spain (2009–2010)

Pandemic Influenza A (H1N1) Infection in Pregnant and Nonpregnant Women in Spain (2009–2010)